此页面是自动翻译的，不保证翻译的准确性。请参阅 英文版 对于源文本。

Brentuximab Vedotin 和联合化疗治疗患有 IIB、IIIB、IVA 或 IVB 期霍奇金淋巴瘤的儿童和年轻人

2026年10月15日 更新者：National Cancer Institute (NCI)

Brentuximab Vedotin (SGN-35) 用于儿童和年轻人新诊断的高危经典霍奇金淋巴瘤 (cHL) 的随机 3 期研究

This phase III trial studies brentuximab vedotin and combination chemotherapy to see how well they work compared to combination chemotherapy alone in treating children and young adults with stage IIB with bulk, stage IIIB, IVA, or IVB Hodgkin lymphoma. Combinations of biological substances in brentuximab vedotin may be able to carry cancer-killing substances directly to Hodgkin lymphoma cells. Chemotherapy drugs, such as doxorubicin hydrochloride, bleomycin sulfate, vincristine sulfate, etoposide, prednisone, and cyclophosphamide, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known if combination chemotherapy is more effective with or without brentuximab vedotin in treating children with high-risk Hodgkin lymphoma.

研究概览

地位

主动，不招人

条件

干预/治疗

详细说明

PRIMARY OBJECTIVE:

I. To assess the event free survival (EFS) of a novel regimen incorporating brentuximab vedotin (Bv; Adcetris) in the chemotherapy backbone of doxorubicin hydrochloride (doxorubicin) (Adriamycin), vincristine sulfate (vincristine), etoposide, prednisone and cyclophosphamide (Bv-AVEPC) in newly diagnosed high-risk classical Hodgkin lymphoma (cHL) compared to those treated with Adriamycin, bleomycin sulfate, vincristine sulfate, etoposide, prednisone, and cyclophosphamide (ABVE-PC).

SECONDARY OBJECTIVES:

I. To determine whether children/young adults with high-risk cHL treated with Bv-AVEPC have a higher rate of early response (determined by fludeoxyglucose F 18 [FDG]-positron emission tomography [PET]) and a reduction in protocol directed radiation therapy (RT) compared to those treated with ABVE-PC.

II. To compare the rate of neuropathy (>= grade 3) among patients treated on the Bv-AVEPC (experimental arm) to patients treated on the ABVE-PC (standard arm).

EXPLORATORY OBJECTIVES:

I. To validate and compare the Childhood Hodgkin International Prognostic Score (CHIPS) to conventional Ann Arbor stage (stages II B with bulk, III B, IV A or B) in predicting outcome in high-risk childhood cHL.

II. To determine the incidence of preferentially expressed antigen in melanoma (PRAME) and testis-specific antigens in Epstein-Barr virus (EBV)- cHL tumors and the incidence of EBV antigens (Epstein-Barr nuclear antigen 1 [EBNA1], Epstein-Barr virus latent membrane protein 1 [LMP1], large multifunctional peptidase 2 [LMP2]) in EBV+ cHL tumors, with the goal of developing strategies to integrate cellular therapy into treatment for newly diagnosed high-risk cHL. (Biology) III. To incorporate qualitative visual FDG-PET into response-directed treatment algorithms and explore quantitative FDG-PET and computed tomography (CT) definitions of tumor burden and response for incorporation into next generation pediatric cHL risk-stratification schemes, exploring the extension of these algorithms to young adults. (Imaging) IV. To evaluate the reduction in normal tissue irradiation associated with the current treatment approach compared to the volume of historic involved field radiation therapy (IFRT) fields. (Radiation Therapy) V. To evaluate EFS and patterns of relapse following protocol-specified RT utilization and treatment volumes. (Radiation Therapy) VI. To characterize the extent of chemotherapy induced peripheral neuropathy (CIPN), as reported by patients and parent proxies, through serial administration of the Functional Assessment of Cancer Therapy-Gynecologic Oncology Group-Neurotoxicity (FACT-GOG-NTX). (Patient Reported Outcomes [PRO] of Peripheral Neuropathy and Health-Related Quality of Life) VII. To describe the Health-Related Quality of Life (HRQL) consequences of peripheral neuropathy over time by correlating total neuropathy scale scores with the individual items with the Child Health Ratings Inventories (CHRIs)-Global scale (e.g., physical health, pain, emotional functioning). (PRO of Peripheral Neuropathy and Health-Related Quality of Life) VIII. To perform a cross validation of the FACT-GOG-NTX with the Total Neuropathy Score-Pediatric Vincristine (TNS-PV) to determine the performance of both measures with the use of brentuximab vedotin in a limited institutional approach in children and adolescents with cHL. (PRO of Peripheral Neuropathy and Health-Related Quality of Life) IX. To assess the resource use and cost implications of Bv in combination with chemotherapy and radiotherapy (RT) for newly diagnosed high-risk cHL in children and young adults. (Economic) X. To estimate the risk of relapse among rapidly responding lesions (RRL) subjects that have at least one lesion that is Deauville 3 at PET 2. (Follow-up of Deauville score 3 lesions on FDG-PET imaging [confirmed by central imaging review]) XI. To characterize the pharmacokinetics of brentuximab vedotin in children < 13 years of age.

OUTLINE: Patients are randomized to 1 of 2 treatment arms.

ARM I (ABVE-PC): Patients receive doxorubicin hydrochloride intravenously (IV) over on days 1-2, bleomycin sulfate IV or subcutaneously (SC) on days 1 and 8, vincristine sulfate IV on days 1 and 8, etoposide IV on days 1-3, prednisone orally (PO) twice daily (BID) or methylprednisolone IV on days 1-7, and cyclophosphamide IV on days 1 and 2.

ARM II (Bv-AVEPC): Patients receive brentuximab vedotin IV on day 1. Patients also receive doxorubicin hydrochloride, etoposide, prednisone or methylprednisolone, and cyclophosphamide as in Arm I and vincristine sulfate IV on day 8.

In both arms, treatment repeats every 21 days for 5 cycles in the absence of disease progression or unacceptable toxicity. Granulocyte simulating factor (GCSF) or equivalent is given on both arms.

After completion of study treatment, patients are followed up at 3, 6, 9, 12, 18, 24, 30, 36, and 48 months.

研究类型

介入性

注册 (实际的)

600

阶段

  • 第三阶段

联系人和位置

本节提供了进行研究的人员的详细联系信息，以及有关进行该研究的地点的信息。

学习地点

  • 加拿大
      • Québec、加拿大、G1V 4G2
        • CHU de Quebec-Centre Hospitalier de l'Universite Laval (CHUL)
    • Alberta
      • Calgary、Alberta、加拿大、T3B 6A8
        • Alberta Children's Hospital
      • Edmonton、Alberta、加拿大、T6G 2B7
        • University of Alberta Hospital
    • British Columbia
      • Vancouver、British Columbia、加拿大、V6H 3V4
        • British Columbia Children's Hospital
    • Manitoba
      • Winnipeg、Manitoba、加拿大、R3E 0V9
        • CancerCare Manitoba
    • Nova Scotia
      • Halifax、Nova Scotia、加拿大、B3K 6R8
        • IWK Health Centre
    • Ontario
      • Hamilton、Ontario、加拿大、L8N 3Z5
        • McMaster Children's Hospital at Hamilton Health Sciences
      • Kingston、Ontario、加拿大、K7L 2V7
        • Kingston Health Sciences Centre
      • London、Ontario、加拿大、N6A 5W9
        • Children's Hospital
      • Ottawa、Ontario、加拿大、K1H 8L1
        • Children's Hospital of Eastern Ontario
      • Toronto、Ontario、加拿大、M5G 1X8
        • Hospital for Sick Children
    • Quebec
      • Montreal、Quebec、加拿大、H3H 1P3
        • The Montreal Children's Hospital of the MUHC
      • Montreal、Quebec、加拿大、H3T 1C5
        • Centre Hospitalier Universitaire Sainte-Justine
    • Saskatchewan
      • Saskatoon、Saskatchewan、加拿大、S7N 4H4
        • Saskatoon Cancer Centre
  • 波多黎各
      • Caguas、波多黎各、00726
        • HIMA San Pablo Oncologic Hospital
      • San Juan、波多黎各、00926
        • University Pediatric Hospital
      • San Juan、波多黎各、00912
        • San Jorge Children's Hospital
  • 美国
    • Alabama
      • Birmingham、Alabama、美国、35233
        • Children's Hospital of Alabama
      • Mobile、Alabama、美国、36604
        • USA Health Strada Patient Care Center
    • Alaska
      • Anchorage、Alaska、美国、99508
        • Providence Alaska Medical Center
    • Arizona
      • Mesa、Arizona、美国、85202
        • Banner Children's at Desert
      • Phoenix、Arizona、美国、85016
        • Phoenix Childrens Hospital
      • Tucson、Arizona、美国、85719
        • Banner University Medical Center - Tucson
    • Arkansas
      • Little Rock、Arkansas、美国、72202-3591
        • Arkansas Children's Hospital
    • California
      • Downey、California、美国、90242
        • Kaiser Permanente Downey Medical Center
      • Duarte、California、美国、91010
        • City of Hope Comprehensive Cancer Center
      • Loma Linda、California、美国、92354
        • Loma Linda University Medical Center
      • Long Beach、California、美国、90806
        • Miller Children's and Women's Hospital Long Beach
      • Los Angeles、California、美国、90048
        • Cedars-Sinai Medical Center
      • Los Angeles、California、美国、90027
        • Children's Hospital Los Angeles
      • Madera、California、美国、93636
        • Valley Children's Hospital
      • Oakland、California、美国、94611
        • Kaiser Permanente-Oakland
      • Orange、California、美国、92868
        • Children's Hospital of Orange County
      • Sacramento、California、美国、95816
        • Sutter Medical Center Sacramento
      • Sacramento、California、美国、95817
        • University of California Davis Comprehensive Cancer Center
      • San Diego、California、美国、92123
        • Rady Children's Hospital - San Diego
      • San Diego、California、美国、92134
        • Naval Medical Center -San Diego
      • Santa Barbara、California、美国、93102
        • Santa Barbara Cottage Hospital
      • Torrance、California、美国、90502
        • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
    • Colorado
      • Aurora、Colorado、美国、80045
        • Children's Hospital Colorado
      • Denver、Colorado、美国、80218
        • Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center
    • Connecticut
      • Hartford、Connecticut、美国、06106
        • Connecticut Children's Medical Center
      • New Haven、Connecticut、美国、06520
        • Yale University
    • Delaware
      • Wilmington、Delaware、美国、19803
        • Alfred I duPont Hospital for Children
    • District of Columbia
      • Washington D.C.、District of Columbia、美国、20010
        • Children's National Medical Center
      • Washington D.C.、District of Columbia、美国、20007
        • MedStar Georgetown University Hospital
    • Florida
      • Fort Lauderdale、Florida、美国、33316
        • Broward Health Medical Center
      • Fort Myers、Florida、美国、33908
        • Golisano Children's Hospital of Southwest Florida
      • Gainesville、Florida、美国、32610
        • UF Health Cancer Institute - Gainesville
      • Hollywood、Florida、美国、33021
        • Memorial Regional Hospital/Joe DiMaggio Children's Hospital
      • Jacksonville、Florida、美国、32207
        • Nemours Children's Clinic-Jacksonville
      • Miami、Florida、美国、33155
        • Nicklaus Children's Hospital
      • Miami、Florida、美国、33136
        • University of Miami Miller School of Medicine-Sylvester Cancer Center
      • Miami、Florida、美国、33176
        • Miami Cancer Institute
      • Orlando、Florida、美国、32827
        • Nemours Children's Hospital
      • Orlando、Florida、美国、32803
        • AdventHealth Orlando
      • Orlando、Florida、美国、32806
        • Arnold Palmer Hospital for Children
      • Pensacola、Florida、美国、32504
        • Nemours Children's Clinic - Pensacola
      • St. Petersburg、Florida、美国、33701
        • Johns Hopkins All Children's Hospital
      • Tampa、Florida、美国、33606
        • Tampa General Hospital
      • Tampa、Florida、美国、33607
        • Saint Joseph's Hospital/Children's Hospital-Tampa
      • West Palm Beach、Florida、美国、33407
        • Saint Mary's Medical Center
    • Georgia
      • Atlanta、Georgia、美国、30329
        • Children's Healthcare of Atlanta - Arthur M Blank Hospital
      • Augusta、Georgia、美国、30912
        • Augusta University Medical Center
      • Savannah、Georgia、美国、31404
        • Memorial Health University Medical Center
    • Hawaii
      • Honolulu、Hawaii、美国、96826
        • Kapiolani Medical Center for Women and Children
    • Idaho
      • Boise、Idaho、美国、83712
        • Saint Luke's Cancer Institute - Boise
    • Illinois
      • Chicago、Illinois、美国、60637
        • University of Chicago Comprehensive Cancer Center
      • Chicago、Illinois、美国、60612
        • University of Illinois
      • Chicago、Illinois、美国、60611
        • Lurie Children's Hospital-Chicago
      • Maywood、Illinois、美国、60153
        • Loyola University Medical Center
      • Oak Lawn、Illinois、美国、60453
        • Advocate Children's Hospital-Oak Lawn
      • Park Ridge、Illinois、美国、60068
        • Advocate Children's Hospital-Park Ridge
      • Peoria、Illinois、美国、61637
        • OSF Children's Hospital of Illinois
      • Springfield、Illinois、美国、62702
        • Southern Illinois University School of Medicine
    • Indiana
      • Indianapolis、Indiana、美国、46202
        • Riley Hospital for Children
      • Indianapolis、Indiana、美国、46260
        • Ascension Saint Vincent Indianapolis Hospital
    • Iowa
      • Des Moines、Iowa、美国、50309
        • Blank Children's Hospital
      • Iowa City、Iowa、美国、52242
        • University of Iowa/Holden Comprehensive Cancer Center
    • Kentucky
      • Lexington、Kentucky、美国、40536
        • University of Kentucky/Markey Cancer Center
      • Louisville、Kentucky、美国、40202
        • Norton Children's Hospital
    • Louisiana
      • New Orleans、Louisiana、美国、70121
        • Ochsner Medical Center Jefferson
      • New Orleans、Louisiana、美国、70118
        • Children's Hospital New Orleans
    • Maine
      • Bangor、Maine、美国、04401
        • Eastern Maine Medical Center
    • Maryland
      • Baltimore、Maryland、美国、21287
        • Johns Hopkins University/Sidney Kimmel Cancer Center
      • Baltimore、Maryland、美国、21215
        • Sinai Hospital of Baltimore
      • Baltimore、Maryland、美国、21201
        • University of Maryland/Greenebaum Cancer Center
      • Bethesda、Maryland、美国、20889-5600
        • Walter Reed National Military Medical Center
    • Massachusetts
      • Boston、Massachusetts、美国、02111
        • Tufts Children's Hospital
      • Springfield、Massachusetts、美国、01199
        • Baystate Medical Center
      • Worcester、Massachusetts、美国、01655
        • UMass Memorial Medical Center - University Campus
    • Michigan
      • Ann Arbor、Michigan、美国、48109
        • C S Mott Children's Hospital
      • Detroit、Michigan、美国、48201
        • Wayne State University/Karmanos Cancer Institute
      • Detroit、Michigan、美国、48236
        • Henry Ford Health Saint John Hospital
      • East Lansing、Michigan、美国、48823
        • Michigan State University
      • Flint、Michigan、美国、48503
        • Hurley Medical Center
      • Grand Rapids、Michigan、美国、49503
        • Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital
      • Kalamazoo、Michigan、美国、49007
        • Bronson Methodist Hospital
      • Royal Oak、Michigan、美国、48073
        • Corewell Health Children's
    • Minnesota
      • Minneapolis、Minnesota、美国、55404
        • Children's Hospitals and Clinics of Minnesota - Minneapolis
      • Minneapolis、Minnesota、美国、55455
        • University of Minnesota/Masonic Cancer Center
      • Rochester、Minnesota、美国、55905
        • Mayo Clinic in Rochester
    • Mississippi
      • Jackson、Mississippi、美国、39216
        • University of Mississippi Medical Center
    • Missouri
      • Columbia、Missouri、美国、65212
        • University of Missouri Children's Hospital
      • Kansas City、Missouri、美国、64108
        • Children's Mercy Hospitals and Clinics
      • St Louis、Missouri、美国、63110
        • Washington University School of Medicine
      • St Louis、Missouri、美国、63141
        • Mercy Hospital Saint Louis
      • St Louis、Missouri、美国、63104
        • Cardinal Glennon Children's Medical Center
    • Nebraska
      • Omaha、Nebraska、美国、68198
        • University of Nebraska Medical Center
      • Omaha、Nebraska、美国、68114
        • Children's Hospital and Medical Center of Omaha
    • Nevada
      • Las Vegas、Nevada、美国、89144
        • Summerlin Hospital Medical Center
      • Las Vegas、Nevada、美国、89109
        • Sunrise Hospital and Medical Center
      • Las Vegas、Nevada、美国、89135
        • Alliance for Childhood Diseases/Cure 4 the Kids Foundation
      • Las Vegas、Nevada、美国、89102
        • University Medical Center of Southern Nevada
    • New Hampshire
      • Lebanon、New Hampshire、美国、03756
        • Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
    • New Jersey
      • Hackensack、New Jersey、美国、07601
        • Hackensack University Medical Center
      • Morristown、New Jersey、美国、07960
        • Morristown Medical Center
      • New Brunswick、New Jersey、美国、08901
        • Saint Peter's University Hospital
      • New Brunswick、New Jersey、美国、08903
        • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital
      • Newark、New Jersey、美国、07112
        • Newark Beth Israel Medical Center
      • Paterson、New Jersey、美国、07503
        • Saint Joseph's Regional Medical Center
    • New Mexico
      • Albuquerque、New Mexico、美国、87106
        • University of New Mexico Cancer Center
    • New York
      • Albany、New York、美国、12208
        • Albany Medical Center
      • Buffalo、New York、美国、14263
        • Roswell Park Cancer Institute
      • Mineola、New York、美国、11501
        • NYU Langone Hospital - Long Island
      • New Hyde Park、New York、美国、11040
        • The Steven and Alexandra Cohen Children's Medical Center of New York
      • New York、New York、美国、10065
        • Memorial Sloan Kettering Cancer Center
      • New York、New York、美国、10029
        • Mount Sinai Hospital
      • New York、New York、美国、10032
        • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
      • New York、New York、美国、10065
        • NYP/Weill Cornell Medical Center
      • New York、New York、美国、10016
        • Laura and Isaac Perlmutter Cancer Center at NYU Langone
      • Rochester、New York、美国、14642
        • University of Rochester
      • Stony Brook、New York、美国、11794
        • Stony Brook University Medical Center
      • Syracuse、New York、美国、13210
        • State University of New York Upstate Medical University
      • The Bronx、New York、美国、10467
        • Montefiore Medical Center - Moses Campus
    • North Carolina
      • Asheville、North Carolina、美国、28801
        • Mission Hospital
      • Chapel Hill、North Carolina、美国、27599
        • UNC Lineberger Comprehensive Cancer Center
      • Charlotte、North Carolina、美国、28203
        • Carolinas Medical Center/Levine Cancer Institute
      • Charlotte、North Carolina、美国、28204
        • Novant Health Presbyterian Medical Center
      • Durham、North Carolina、美国、27710
        • Duke University Medical Center
      • Greenville、North Carolina、美国、27834
        • East Carolina University
      • Winston-Salem、North Carolina、美国、27157
        • Wake Forest University Health Sciences
    • North Dakota
      • Fargo、North Dakota、美国、58122
        • Sanford Broadway Medical Center
    • Ohio
      • Akron、Ohio、美国、44308
        • Children's Hospital Medical Center of Akron
      • Cincinnati、Ohio、美国、45229
        • Cincinnati Children's Hospital Medical Center
      • Cleveland、Ohio、美国、44195
        • Cleveland Clinic Foundation
      • Cleveland、Ohio、美国、44106
        • Rainbow Babies and Childrens Hospital
      • Columbus、Ohio、美国、43205
        • Nationwide Children's Hospital
      • Dayton、Ohio、美国、45404
        • Dayton Children's Hospital
      • Toledo、Ohio、美国、43606
        • ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital
    • Oklahoma
      • Oklahoma City、Oklahoma、美国、73104
        • University of Oklahoma Health Sciences Center
    • Oregon
      • Portland、Oregon、美国、97239
        • Oregon Health and Science University
      • Portland、Oregon、美国、97227
        • Legacy Emanuel Children's Hospital
    • Pennsylvania
      • Allentown、Pennsylvania、美国、18103
        • Lehigh Valley Hospital-Cedar Crest
      • Bethlehem、Pennsylvania、美国、18017
        • Lehigh Valley Hospital - Muhlenberg
      • Danville、Pennsylvania、美国、17822
        • Geisinger Medical Center
      • Hershey、Pennsylvania、美国、17033
        • Penn State Children's Hospital
      • Philadelphia、Pennsylvania、美国、19104
        • Children's Hospital of Philadelphia
      • Philadelphia、Pennsylvania、美国、19134
        • Saint Christopher's Hospital for Children
      • Pittsburgh、Pennsylvania、美国、15224
        • Children's Hospital of Pittsburgh of UPMC
    • Rhode Island
      • Providence、Rhode Island、美国、02903
        • Rhode Island Hospital
    • South Carolina
      • Charleston、South Carolina、美国、29425
        • Medical University of South Carolina
      • Columbia、South Carolina、美国、29203
        • Prisma Health Richland Hospital
      • Greenville、South Carolina、美国、29605
        • BI-LO Charities Children's Cancer Center
    • South Dakota
      • Sioux Falls、South Dakota、美国、57117-5134
        • Sanford USD Medical Center - Sioux Falls
    • Tennessee
      • Chattanooga、Tennessee、美国、37403
        • T C Thompson Children's Hospital
      • Knoxville、Tennessee、美国、37916
        • East Tennessee Childrens Hospital
      • Nashville、Tennessee、美国、37232
        • Vanderbilt University/Ingram Cancer Center
      • Nashville、Tennessee、美国、37203
        • The Children's Hospital at TriStar Centennial
    • Texas
      • Austin、Texas、美国、78723
        • Dell Children's Medical Center of Central Texas
      • Corpus Christi、Texas、美国、78411
        • Driscoll Children's Hospital
      • Dallas、Texas、美国、75390
        • UT Southwestern/Simmons Cancer Center-Dallas
      • Dallas、Texas、美国、75230
        • Medical City Dallas Hospital
      • El Paso、Texas、美国、79905
        • El Paso Children's Hospital
      • Fort Worth、Texas、美国、76104
        • Cook Children's Medical Center
      • Houston、Texas、美国、77030
        • UT MD Anderson Cancer Center
      • Houston、Texas、美国、77030
        • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
      • Lubbock、Texas、美国、79410
        • Covenant Children's Hospital
      • Lubbock、Texas、美国、79415
        • UMC Cancer Center / UMC Health System
      • San Antonio、Texas、美国、78229
        • University of Texas Health Science Center at San Antonio
      • San Antonio、Texas、美国、78207
        • Children's Hospital of San Antonio
      • San Antonio、Texas、美国、78229
        • Methodist Children's Hospital of South Texas
      • Temple、Texas、美国、76508
        • Scott and White Memorial Hospital
    • Utah
      • Salt Lake City、Utah、美国、84113
        • Primary Children's Hospital
    • Vermont
      • Burlington、Vermont、美国、05405
        • University of Vermont and State Agricultural College
    • Virginia
      • Charlottesville、Virginia、美国、22908
        • University of Virginia Cancer Center
      • Falls Church、Virginia、美国、22042
        • Inova Fairfax Hospital
      • Norfolk、Virginia、美国、23507
        • Children's Hospital of The King's Daughters
      • Richmond、Virginia、美国、23298
        • VCU Massey Comprehensive Cancer Center
    • Washington
      • Seattle、Washington、美国、98105
        • Seattle Children's Hospital
      • Spokane、Washington、美国、99204
        • Providence Sacred Heart Medical Center and Children's Hospital
      • Tacoma、Washington、美国、98405
        • Mary Bridge Children's Hospital and Health Center
      • Tacoma、Washington、美国、98431
        • Madigan Army Medical Center
    • West Virginia
      • Charleston、West Virginia、美国、25304
        • Vandalia Health/CAMC Institute for Academic Medicine
      • Morgantown、West Virginia、美国、26506
        • West Virginia University Healthcare
    • Wisconsin
      • Green Bay、Wisconsin、美国、54301
        • Saint Vincent Hospital Cancer Center Green Bay
      • Madison、Wisconsin、美国、53792
        • University of Wisconsin Carbone Cancer Center - University Hospital
      • Marshfield、Wisconsin、美国、54449
        • Marshfield Medical Center-Marshfield
      • Milwaukee、Wisconsin、美国、53226
        • Children's Hospital of Wisconsin

参与标准

研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

2年 至 22年 (孩子、成人)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Patients with newly diagnosed, pathologically confirmed cHL meeting one of the following Ann Arbor stages are eligible:

    • Stage IIB with bulk

    • Stage IIIB

    • Stage IVA

    • Stage IVB

      • If study eligibility by staging is uncertain, consultation with Imaging and Radiation Oncology Core (IROC) Rhode Island (RI) may be obtained prior to study enrollment

  • Creatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 mL/min/1.73 m^2 or a serum creatinine based on age/gender as follows (performed within 14 days prior to enrollment):

    • 2 to < 6 years: male 0.8 mg/dL, female 0.8 mg/dL
    • 6 to < 10 years: male 1 mg/dL, female 1 mg/dL
    • 10 to < 13 years: male 1.2 mg/dL, female 1.2 mg/dL
    • 13 to < 16 years: male 1.5 mg/dL, female 1.4 mg/dL
    • >= 16 years: male 1.7 mg/dL, female 1.4 mg/dL

  • Total bilirubin =< 1.5 x upper limit of normal (ULN) for age (performed within 14 days prior to enrollment)

  • Serum glutamic oxaloacetic transaminase (SGOT) (aspartate transaminase [AST]) or serum glutamate pyruvate transaminase (SGPT) (alanine transaminase [ALT]) < 2.5 x upper limit of normal (ULN) for age (performed within 14 days prior to enrollment)

  • Shortening fraction of >= 27% by echocardiogram, or ejection fraction of >= 50% by radionuclide angiogram

  • Forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) > 60% by pulmonary function test (PFT), unless due to large mediastinal mass from Hodgkin lymphoma (HL)

  • For children who are unable to cooperate for PFTs, the criteria are: no evidence of dyspnea at rest, no exercise intolerance, and a pulse oximetry reading of > 92% on room air

  • All patients and/or their parents or legal guardians must sign a written informed consent

  • All institutional, Food and Drug Administration (FDA), and National Cancer Institute (NCI) requirements for human studies must be met

Exclusion Criteria:

  • Patients with nodular lymphocyte-predominant HL
  • Patients with an immunodeficiency that existed prior to diagnosis, such as primary immunodeficiency syndromes, organ transplant recipients and children on current systemic immunosuppressive agents are not eligible
  • Patients who are pregnant; (since fetal toxicities and teratogenic effects have been noted for several of the study drugs, a negative pregnancy test is required for female patients of childbearing potential)
  • Lactating females who plan to breastfeed
  • Sexually active patients of reproductive potential who have not agreed to use an effective contraceptive method for the duration of their study participation and for 30 days after the last dose of chemotherapy
  • Patients known to be positive for human immunodeficiency virus (HIV) are not eligible
  • Patients who have received any previous chemotherapy or radiation therapy are not eligible
  • Patients who received systemic corticosteroids within 28 days of enrollment on this protocol, except as specified, are not eligible

学习计划

本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。

研究是如何设计的？

设计细节

  • 主要用途：治疗
  • 分配：随机化
  • 介入模型：并行分配
  • 屏蔽：单身的

武器和干预

参与者组/臂
干预/治疗
有源比较器：Arm I (ABVE-PC)

Patients receive doxorubicin hydrochloride IV over on days 1-2, bleomycin sulfate IV or SC on days 1 and 8, vincristine sulfate IV on days 1 and 8, etoposide IV on days 1-3, prednisone orally PO BID or methylprednisolone IV on days 1-7, and cyclophosphamide IV on days 1 and 2. Treatment repeats every 21 days for 5 cycles in the absence of disease progression or unacceptable toxicity.
其他：Laboratory Biomarker Analysis

Correlative studies

其他：Quality-of-Life Assessment

Ancillary studies

其他名称：
  • 生活质量评估
药品：Cyclophosphamide

Given IV

其他名称：
  • 胞毒素
  • CTX
  • (-)-环磷酰胺
  • 2H-1,3,2-氧氮杂膦，2-[双（2-氯乙基）氨基]四氢-，2-氧化物，一水合物
  • 卡洛生
  • 环磷酰胺
  • 环草醛
  • 克拉芬
  • CP一水合物
  • 循环电池
  • 环胚素
  • 环爆碱
  • 环磷酰胺一水合物
  • 环磷烷
  • 环磷脂
  • 环素
  • 环孢菌素
  • 胞磷
  • 胞磷烷
  • 磷脂龙
  • Genoxal
  • Genuxal
  • 雷多西那
  • 米托生
  • 新星
  • 重免疫
  • 赛克磷酰胺
  • WR- 138719
  • 阿斯塔B 518
  • B-518
  • WR-138719
  • 乙518
  • B518
  • WR 138719
  • WR138719
  • Frindovyx
药品：Doxorubicin Hydrochloride

Given IV

其他名称：
  • 阿霉素
  • 5,12-并萘二酮，10-[(3-氨基-2,3,6-三脱氧-α-L-来氧代-己吡喃糖基)氧基]-7,8, 9,10-四氢-6,8,11-三羟基-8-(羟基乙酰基)-1-甲氧基-, 盐酸盐, (8S-cis)- (9CI)
  • 广告管理公司
  • 盐酸阿霉素
  • 阿霉素 PFS
  • 阿霉素RDF
  • 阿霉素，盐酸盐
  • Adriblastina
  • 阿得拉碱
  • 阿地美达
  • 氯霉素
  • DOX
  • DOXO细胞
  • 多索伦
  • 阿霉素盐酸盐
  • 农杆菌
  • FI 106
  • FI-106
  • 羟基柔红霉素
  • 橡胶
  • FI106
药品：Prednisone

Given PO

其他名称：
  • 达美松
  • 奥拉松
  • .delta.1-可的松
  • 1, 2-脱氢可的松
  • 阿达松
  • 皮质醇
  • 达考汀
  • 德考坦
  • 去氧硫醇
  • 德克顿
  • Delta 1-可的松
  • 三角穹顶
  • 三角可烯
  • 三角可的松
  • 三角洲脱氢可的松
  • 德尔蒂森
  • 三角洲
  • 经济松
  • 利沙克特
  • 美保生-F
  • 麦考坦
  • 奥菲索罗纳
  • 帕纳福特
  • 松脂-S
  • 伞骨
  • Perrigo 泼尼松
  • 预测
  • 泼尼松-M
  • 泼尼可特
  • 泼尼地布
  • 泼尼龙加
  • 预付款
  • 泼尼松 Intensol
  • 泼尼松
  • 泼尼通
  • 普罗米芬
  • 雷约斯
  • 伺服松
  • SK-泼尼松
药品：Vincristine Sulfate

Given IV

其他名称：
  • 致癌素
  • 基克里斯汀
  • 硫酸亮绿新碱
  • 硫酸白新碱
  • 长春
  • 长春甙
  • 万可乐
  • 硫酸长春新碱
其他：Questionnaire Administration

Ancillary studies

药品：Etoposide

Given IV

其他名称：
  • 去甲基鬼臼毒素乙苷
  • EPEG
  • 拉斯特
  • 拓扑萨
  • 韦贝斯
  • 副总裁 16
  • 副总裁 16-213
  • VP-16
  • VP-16-213
  • VP16
  • 副总裁 16213
  • VP-16213
  • VP16213
其他：Pharmacological Study

Correlative studies

生物：Bleomycin Sulfate

Given IV or SC

其他名称：
  • 博莱辛
  • 布诺生
  • 布兰诺生
  • 博尔莫霉素
  • Bleo细胞
  • Bleo-S
  • 布勒姆
  • 博来霉素磺胺类
  • 博来霉素硫酸盐
  • 碧兰
  • 石油蓝
药品：Methylprednisolone

Given IV

其他名称：
  • 美乐
  • 怀考特
  • 阿德龙
  • 卡伯德尔塔
  • DepMedalone
  • Depo Moderin
  • 地泊尼松龙
  • 杜拉龙
  • 埃梅蒂皮
  • 芝麻酮
  • 固醇
  • 美德龙 21
  • 中级
  • 美乐宝
  • 美卓酮
  • 巨星
  • 美普龙
  • 甲泼尼龙
  • 美替倍松可溶性
  • 地铁
  • 甲氧普林
  • 美泰舒龙
  • Predni-M-Tablinen
  • 泼尼松
  • 放射线
  • 赛罗普酚
  • 索泼酮
  • 苏米考特
  • 乌尔巴松
  • Veriderm美多尔
实验性的：ARM II (Bv-AVEPC)

Patients receive brentuximab vedotin IV on day 1. Patients also receive doxorubicin hydrochloride, etoposide, prednisone or methylprednisolone, and cyclophosphamide as in Arm I and vincristine sulfate IV on day 8. Treatment repeats every 21 days for 5 cycles in the absence of disease progression or unacceptable toxicity.
其他：Laboratory Biomarker Analysis

Correlative studies

其他：Quality-of-Life Assessment

Ancillary studies

其他名称：
  • 生活质量评估
药品：Cyclophosphamide

Given IV

其他名称：
  • 胞毒素
  • CTX
  • (-)-环磷酰胺
  • 2H-1,3,2-氧氮杂膦，2-[双（2-氯乙基）氨基]四氢-，2-氧化物，一水合物
  • 卡洛生
  • 环磷酰胺
  • 环草醛
  • 克拉芬
  • CP一水合物
  • 循环电池
  • 环胚素
  • 环爆碱
  • 环磷酰胺一水合物
  • 环磷烷
  • 环磷脂
  • 环素
  • 环孢菌素
  • 胞磷
  • 胞磷烷
  • 磷脂龙
  • Genoxal
  • Genuxal
  • 雷多西那
  • 米托生
  • 新星
  • 重免疫
  • 赛克磷酰胺
  • WR- 138719
  • 阿斯塔B 518
  • B-518
  • WR-138719
  • 乙518
  • B518
  • WR 138719
  • WR138719
  • Frindovyx
药品：Doxorubicin Hydrochloride

Given IV

其他名称：
  • 阿霉素
  • 5,12-并萘二酮，10-[(3-氨基-2,3,6-三脱氧-α-L-来氧代-己吡喃糖基)氧基]-7,8, 9,10-四氢-6,8,11-三羟基-8-(羟基乙酰基)-1-甲氧基-, 盐酸盐, (8S-cis)- (9CI)
  • 广告管理公司
  • 盐酸阿霉素
  • 阿霉素 PFS
  • 阿霉素RDF
  • 阿霉素，盐酸盐
  • Adriblastina
  • 阿得拉碱
  • 阿地美达
  • 氯霉素
  • DOX
  • DOXO细胞
  • 多索伦
  • 阿霉素盐酸盐
  • 农杆菌
  • FI 106
  • FI-106
  • 羟基柔红霉素
  • 橡胶
  • FI106
药品：Prednisone

Given PO

其他名称：
  • 达美松
  • 奥拉松
  • .delta.1-可的松
  • 1, 2-脱氢可的松
  • 阿达松
  • 皮质醇
  • 达考汀
  • 德考坦
  • 去氧硫醇
  • 德克顿
  • Delta 1-可的松
  • 三角穹顶
  • 三角可烯
  • 三角可的松
  • 三角洲脱氢可的松
  • 德尔蒂森
  • 三角洲
  • 经济松
  • 利沙克特
  • 美保生-F
  • 麦考坦
  • 奥菲索罗纳
  • 帕纳福特
  • 松脂-S
  • 伞骨
  • Perrigo 泼尼松
  • 预测
  • 泼尼松-M
  • 泼尼可特
  • 泼尼地布
  • 泼尼龙加
  • 预付款
  • 泼尼松 Intensol
  • 泼尼松
  • 泼尼通
  • 普罗米芬
  • 雷约斯
  • 伺服松
  • SK-泼尼松
药品：Vincristine Sulfate

Given IV

其他名称：
  • 致癌素
  • 基克里斯汀
  • 硫酸亮绿新碱
  • 硫酸白新碱
  • 长春
  • 长春甙
  • 万可乐
  • 硫酸长春新碱
其他：Questionnaire Administration

Ancillary studies

药品：Brentuximab Vedotin

Given IV

其他名称：
  • Adcetris
  • SGN-35
  • cAC10-vcMMAE
  • ADC SGN-35
  • 抗 CD30 抗体药物偶联物 SGN-35
  • 抗CD30单克隆抗体-MMAE SGN-35
  • 抗CD30单克隆抗体-Monomethylauristatin E SGN-35
  • SGN35
  • SGN 35
药品：Etoposide

Given IV

其他名称：
  • 去甲基鬼臼毒素乙苷
  • EPEG
  • 拉斯特
  • 拓扑萨
  • 韦贝斯
  • 副总裁 16
  • 副总裁 16-213
  • VP-16
  • VP-16-213
  • VP16
  • 副总裁 16213
  • VP-16213
  • VP16213
其他：Pharmacological Study

Correlative studies

药品：Methylprednisolone

Given IV

其他名称：
  • 美乐
  • 怀考特
  • 阿德龙
  • 卡伯德尔塔
  • DepMedalone
  • Depo Moderin
  • 地泊尼松龙
  • 杜拉龙
  • 埃梅蒂皮
  • 芝麻酮
  • 固醇
  • 美德龙 21
  • 中级
  • 美乐宝
  • 美卓酮
  • 巨星
  • 美普龙
  • 甲泼尼龙
  • 美替倍松可溶性
  • 地铁
  • 甲氧普林
  • 美泰舒龙
  • Predni-M-Tablinen
  • 泼尼松
  • 放射线
  • 赛罗普酚
  • 索泼酮
  • 苏米考特
  • 乌尔巴松
  • Veriderm美多尔

研究衡量的是什么？

主要结果指标

结果测量
措施说明
大体时间
Event Free Survival (EFS), Where Events Include Disease Progression or Relapse, Second Malignancy, or Death
大体时间：Up to 48 months after the last enrollment

Primary analysis will be based 1-sided log rank test comparison of EFS curves between the 2 randomized arms per intention-to-treat principle. Progression is defined as an ≥50% increase of in the product of the perpendicular diameters of any of the involved nodes or nodal masses or focal organ lesions in sites that were persistently PET positive; or recurrent PET positive lesions (Deauville 4, 5) in sites that had previously been PET negative regardless of change of size, as was the development of new PET avid measurable lesion(s) >1.5cm in any axis, or new sites of assessable disease. Relapse is defined in patients who achieved a prior CR but subsequently has an increase of ≥50% of the PPD in prior nodal or extranodal sites in a recurrently PET positive lesion(s), or the development of new measurable lesion(s) >1.5cm in any axis, or new sites of assessable disease. Second malignancy is defined based on report of a cancer that is not considered to be classic Hodgkin Lymphoma.
Up to 48 months after the last enrollment

次要结果测量

结果测量
措施说明
大体时间
Percentages of Patients With Early Response Defined as no Slow Responding Lesions (SRL) and no Progressive Disease (PD) at Any Disease Sites Determined by Positron Emission Tomography (PET) Per Deauville Criteria Through Central Review
大体时间：After 42 days of chemotherapy

The percentages of patients (with available PET scan) with no SRL and no PD will be compared between the two randomized arms to see if brentuximab vedotin in the chemotherapy backbone of doxorubicin hydrochloride, vincristine sulfate, etoposide, prednisone and cyclophosphamide (Bv-AVEPC) arm has a higher rate of early response compared to doxorubicin hydrochloride, bleomycin sulfate, vincristine sulfate, etoposide, prednisone, and cyclophosphamide (ABVE-PC) arm. Two-sample Z test of proportions at 1-sided alpha level of 0.05 will be used for these comparisons.
After 42 days of chemotherapy
Percentages of Patients Experiencing Grade 3+ Peripheral Neuropathy Assessed by Modified Balis Scale
大体时间：From the enrollment of the patient to the time of analysis or the last follow-up; an average of 3.6 years.

The percentages of patients experiencing grade 3+ peripheral neuropathy assessed by the treating clinician using the modified Balis scale. The "Modified Balis scale of Pediatric Neuropathy" allows clinicians to assign a score for sensory or motor neuropathy symptoms separately. Scores range from 1 to 4 with 1 being the least symptomatic state and 4 indicating a severe debility. The percentages of patients (with a score >/=3) will be compared between the 2 arms by two-sample Z test at 1-sided alpha level of 0.05.
From the enrollment of the patient to the time of analysis or the last follow-up; an average of 3.6 years.

其他结果措施

结果测量
措施说明
大体时间
Childhood International Prognostic Score (CHIPS) Score
大体时间：Baseline

CHIPS will be computed for all patients and summarized by descriptive statistics. Will examine the association between CHIPS and early response by cross-tabulations and Chi-square tests within each arm separately, as well as logistic regression model where early response is the outcome variable and CHIPS the predictor variable combining the 2 arms with adjustment for randomized chemotherapy.
Baseline
Dose of Radiation Received by Normal Tissues Following Chemotherapy on Either Study Arm
大体时间：Up to 48 months

Descriptive statistics will be used to summarize RT doses received by normal tissues on this study. Two-sample t-test will be used to compare the doses received on this study to those on prior studies.
Up to 48 months
Efficacy of Involved Site Radiotherapy (ISRT) by Analyzing the Event-free Survival of Patients Treated With Response-adapted ISRT and by Evaluating Patterns of Relapse Following ISRT
大体时间：Up to 3 years

EFS for patients on each arm as well as those receiving ISRT or those with slow early response (SER) on each arm will be estimated. One-sample log rank test will be used to compare the observed EFS to the assumed baseline of 82% at 3 years to see if the observed EFS is significantly lower than the projection in these subsets.
Up to 3 years
Risk of Relapse Among RRL Subjects That Have at Least One Lesion That is Deauville 3 at PET 2
大体时间：Up to 48 months after the last enrollment

The risk of relapse for cases that are RRL, but have Deauville 3 lesions, will be compared to those that are classified as complete metabolic response at PET2 with solely Deauville 1 or 2 lesions with K-sample test.
Up to 48 months after the last enrollment
Pharmacokinetic (PK) Analyses
大体时间：Pre-dose and end of infusion on day 1, days 2, 3, 8, and 15 of cycle 4 and pre-dose on day 1 and day 22 of cycle 5 (each cycle = 21 days)

PK concentration time profile will be evaluated.
Pre-dose and end of infusion on day 1, days 2, 3, 8, and 15 of cycle 4 and pre-dose on day 1 and day 22 of cycle 5 (each cycle = 21 days)

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

National Cancer Institute (NCI)

调查人员

  • 首席研究员：Sharon M Castellino、Children's Oncology Group

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

有用的网址

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2015年3月19日

初级完成 (实际的)

2021年12月31日

研究完成 (估计的)

2027年10月14日

研究注册日期

首次提交

2014年6月16日

首先提交符合 QC 标准的

2014年6月16日

首次发布 (估计的)

2014年6月18日

研究记录更新

最后更新发布 (实际的)

2026年11月3日

上次提交的符合 QC 标准的更新

2026年10月15日

最后验证

2026年6月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • NCI-2014-01223
  • U10CA180886 (美国 NIH 拨款/合同)
  • NCI-2014-01223 (注册表标识符：CTRP (Clinical Trial Reporting Program))
  • s15-00950
  • AHOD1331 (其他标识符：CTEP)
  • AHOD1331 (其他标识符：Children's Oncology Group)

此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.

订阅